{"title": "Estudio inmunol\u00f3gico de la vacuna RTS,S", "author": null, "url": "https://www.isglobal.org/-/rts-s-vaccine-immunology-study", "hostname": "isglobal.org", "description": "Estudio de correlatos de protecci\u00f3n frente a la malaria despu\u00e9s de la vacunaci\u00f3n con RTS,S/AS01E: Una evaluaci\u00f3n inmunol\u00f3gica exhaustiva en el ensayo cl\u00ednico de Fase III, doble ciego, aleatorizado, multic\u00e9ntrico con un grupo control.", "sitename": "ISGlobal", "date": "2021-10-07", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Eliminaci\u00f3n de la malaria](/news?categoryIds=17612)\nEstudio inmunol\u00f3gico de la vacuna RTS,S\nEstudio de correlatos de protecci\u00f3n frente a la malaria despu\u00e9s de la vacunaci\u00f3n con RTS,S/AS01E: Una evaluaci\u00f3n inmunol\u00f3gica exhaustiva en el ensayo cl\u00ednico de Fase III, doble ciego, aleatorizado, multic\u00e9ntrico con un grupo control\n- Coordinador\n- Carlota Doba\u00f1o\n- P\u00e1gina web\n[http://www.sysmalvac.eu/](http://www.sysmalvac.eu/)\nLa RTS,S es la vacuna candidata m\u00e1s prometedora frente a la malaria que ha demostrado evidencias de protecci\u00f3n. Actualmente se encuentra en etapas avanzadas de ensayo cl\u00ednico de Fase III en ni\u00f1os africanos. Los resultados iniciales han mostrado que la eficacia de la RTS,S es moderada y se han planteado cuestiones sobre la duraci\u00f3n de la protecci\u00f3n, que puede verse afectada por las diferentes intensidades de transmisi\u00f3n de la malaria en los diferentes lugares donde se ha realizado el ensayo. Adem\u00e1s, el modo de acci\u00f3n de la RTS,S contin\u00faa siendo incierto y para el desarrollo de la siguiente generaci\u00f3n de vacunas mejoradas es crucial que se comprendan los mecanismos inmunol\u00f3gicos inducidos por la RTS,S.\nAntes de comenzar el ensayo de Fase III de la RTS,S, un grupo de investigadores dirigido por la Dra. Carlota Doba\u00f1o se reuni\u00f3 para desarrollar y llevar a cabo un estudio multic\u00e9ntrico, ancilar al ensayo cl\u00ednico de Fase III, para investigar las bases inmunol\u00f3gicas de la protecci\u00f3n inducida por la RTS,S. Este estudio inmunol\u00f3gico de la RTS,S se encuentra en una posici\u00f3n excepcional ya que proporciona una \u00fanica y \u00faltima oportunidad para explorar m\u00e1s a fondo y comprender mejor los mecanismos inmunes inducidos por la vacuna y evaluar correlatos de protecci\u00f3n en el contexto de un ensayo cl\u00ednico doble ciego, aleatorizado, y con un grupo control.\nEl descubrimiento de un correlato de protecci\u00f3n supondr\u00e1 un important\u00edsimo logro en la b\u00fasqueda de una vacuna frente a la malaria mucho m\u00e1s eficaz y duradero.\nFinanciadores\n- MIV/PATH, Estados Unidos\n- NIAID/NIH, Estados Unidos\n- S\u00e9ptimo Programa Marco (FP7), Uni\u00f3n Europea\n- FIS/ISCIII, Espa\u00f1a\n- AGAUR, Catalu\u00f1a\nColaboradores\n- Swiss Tropical and Public Health Institute (SwissTPH), Basilea, Suiza; en colaboraci\u00f3n con el Ifakara Health Institute, Bagamoyo Research and Training Centre, Tanzania\n- Institut f\u00fcr Tropenmedizin,, Universit\u00e4tsklinikum T\u00fcbingen (UKT), Alemania; en colaboraci\u00f3n con la Medical Research Unit, Albert Schweitzer Hospital, Lambar\u00e9n\u00e9, Gab\u00f3n\n- Noguchi Memorial Institute for Medical Research, College of Health Sciences (NMIMR); en colaboraci\u00f3n con el Kintampo Health Research Center (KHRC), Ghana\n- Kenya Medical Research Institute/Walter Reed Project (KEMRI/WRP), Kenia\n- KEMRI/Centers for Disease Control and Prevention (KEMRI/CDC), Kenia\n- Institut de Recherche en Sciences de la Sant\u00e9(IRSS)/Centre Muraz, Burkina Faso\n- Centro de Investiga\u00e7\u00e4o em Sa\u00fade de Manhi\u00e7a (CISM), Mozambique; en colaboraci\u00f3n con CRESIB, Espa\u00f1a\n- GlaxoSmithKline (GSK) Rixensart, B\u00e9lgica\n- Malaria Vaccine Initiative (MVI) - Program for Appropriate Technology in Health (PATH), EE.UU.\nColaboradores Externos\n- Center for Vaccinology - Ghent University Hospital (CEVAC), B\u00e9lgica\n- Radboud University Nijmegen Medical Center (RUNMC), Pa\u00edses Bajos\n- Biomedical Primate Research Centre (BPRC), Pa\u00edses Bajos\n- Progenika Biopharma SA (PGK), Bilbao, Espa\u00f1a\n- Anaxomics Biotech S.L. (AX), Barcelona, Espa\u00f1a\n- Harvard School of Public Health (HSPH), The Broad Institute, Boston, EE.UU.\n- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, EE.UU.\n- Seattle Biomedical Research Institute (SBIR), Seattle, EE.UU.\n- National Institute of Allergy and Infectious Diseases (NIAID), EE.UU.\n- Walter Reed Army Institute of Research (WRAIR), EE.UU.\n- University of California Irvine (UCI), EE.UU.\n- Indiana University \u2013 Purdue University Indianapolis, EE.UU.\n- New York University (NYU), EE.UU.\n- Naval Medical Research Center (NMRC), EE.UU.\n- Antigen Discovery Inc (ADi), California, EE.UU.\nOtros proyectos\n[Ver proyectos pasados](/projects?categoryIds=5597611%2C59545)\n[MESA](https://www.isglobal.org/-/malaria-eradication-scientific-alliance-mesa-)\nLa Alianza Cient\u00edfica para la Erradicaci\u00f3n de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicaci\u00f3n de la malaria.\n[NHEPACHA](https://www.isglobal.org/-/nuevas-herramientas-para-el-diagnostico-y-la-evaluacion-del-paciente-con-enfermedad-de-chagas-nhepacha)\nNuevas Herramientas para el Diagn\u00f3stico y la Evaluaci\u00f3n del Paciente con Enfermedad de Chagas\n[Euroleish.net](https://www.isglobal.org/-/euroleishnet)\nControl of Leishmaniasis. From bench to bedside and community\n[GREPIMER](https://www.isglobal.org/-/grepimer)\nGrup de recerca en patolog\u00eda importada i malaties emergents i re-emergents\n[TESEO](https://www.isglobal.org/-/teseo)\nNuevos reg\u00edmenes de quimioterapia y biomarcadores para la enfermedad de Chagas\n[BOHEMIA](https://www.isglobal.org/-/bohemia)\nBroad One Health Endectocide-based Malaria Intervention in Africa\n[ASINTMAL](https://www.isglobal.org/-/asintmal)\nUnravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults\n[GenMoz](https://www.isglobal.org/-/genmoz)\nP. falciparum genomic intelligence in Mozambique\n[ADAM](https://www.isglobal.org/-/adam)\nAdministraci\u00f3n masiva y focal de f\u00e1rmacos antimal\u00e1ricos para avanzar hacia la eliminaci\u00f3n de la malaria en Mozambique: acelerando la implementaci\u00f3n de programas y pol\u00edticas\n[MULTIPLY](https://www.isglobal.org/-/multiply)\nMULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention\n[ECO](https://www.isglobal.org/-/enhanced-equitable-covid19-testing-treatment-bolivia-paraguay)\nEquidad y Optimizaci\u00f3n del Acceso al Diagn\u00f3stico y Tratamiento de la COVID-19 en Bolivia y Paraguay\n[Science4Pandemics](https://www.isglobal.org/-/science4pandemics)\nCitizens engagement digital platform for collective intelligence in pandemics\n[HIDDENVIVAX](https://www.isglobal.org/-/hiddenvivax)\nNovel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria\n[Subclinical Infections in Children and Long Term Health Effects](https://www.isglobal.org/-/subclinical-infections-in-children-and-long-term-health-effects)\nInfection acquisition in early life and health outcomes in childhood - MARATO TV3\n[Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a ant\u00edgenos diana de inmunidad natural y vacunal frente a pat\u00f3genos humanos prominentes](https://www.isglobal.org/-/impacto-de-las-coinfecciones-en-el-balance-de-respuestas-de-anticuerpos-y-linfocitos-t-helper-a-antigenos-diana-de-inmunidad-natural-y-vacunal-frente-)\nProject Code: PI20/00866\n[Herramienta innovadora de detecci\u00f3n de enfermedades y vacunaci\u00f3n a poblaci\u00f3n inmigrante en riesgo en Espa\u00f1a](https://www.isglobal.org/-/herramienta-innovadora-de-deteccion-de-enfermedades-y-vacunacion-a-poblacion-inmigrante-en-riesgo-en-espana)\nProject Code: PI21/00651\n[MENA Migrant Health](https://www.isglobal.org/-/mena-migrant-health)\nTransforming data collection and surveillance to drive migrant health research, care and policy\n[SexMal](https://www.isglobal.org/-/sexmal)\nSocial affairs and sex in P. falciparum: implications for malaria elimination\n[G_SensMalaria](https://www.isglobal.org/-/g_sensmalaria)\nPortable Graphene Multiplex Electrochemical Sensor for Rapid Detection of Severe Malaria\n[EpiGen](https://www.isglobal.org/-/epigen-building-scalable-pathogen-genomic-epidemiology-in-ethiopia)\nBuilding Scalable Pathogen Genomic Epidemiology in Ethiopia", "language": null, "image": "https://www.isglobal.org/documents/10179/15976/IMG_3821.png/28ea86c2-8261-4f3a-b402-7d21dee0864f?t=1385726028000", "pagetype": "article", "links": ["/", "#", "/job-opportunities", "/press", "/find-us", "#", "/ca/-/rts-s-vaccine-immunology-study", "/en/-/rts-s-vaccine-immunology-study", "/es/-/rts-s-vaccine-immunology-study", "http://www.facebook.com/isglobal", "http://twitter.com/ISGLOBALorg", "https://www.linkedin.com/company/1992859/", "https://www.instagram.com/isglobalorg/", "https://www.youtube.com/user/ISGLOBALorg", "/es/covid19/haz-un-donativo", "https://www.isglobal.org/about-us", "#", "https://www.isglobal.org/quienes-somos", "#", "https://www.isglobal.org/how-we-work", "https://www.isglobal.org/nuestra-historia", "https://www.isglobal.org/governance", "https://www.isglobal.org/transparencia", "https://www.isglobal.org/compliance", "https://www.isglobal.org/research-integrity", "https://www.isglobal.org/igualdad-de-genero", "https://www.isglobal.org/our-team", "https://www.isglobal.org/where", "https://www.isglobal.org/trabaja-con-nosotros", "#", "https://www.isglobal.org/job-opportunities", "https://www.isglobal.org/consultorias", "https://www.isglobal.org/contrataciones", "https://www.isglobal.org/hrs4r", "https://www.isglobal.org/find-us", "https://www.isglobal.org/research", "#", "https://www.isglobal.org/research/what-we-do", "#", "https://www.isglobal.org/researchers", "https://www.isglobal.org/documents/10179/6583525/CC+OMS+eng.pdf/34bfe715-063b-452e-ada2-7e33d4e5a276", "https://www.isglobal.org/consultancy", "https://www.isglobal.org/sabbaticals", "https://www.isglobal.org/voluntariado", "https://www.isglobal.org/severo-ochoa", "#", "https://www.isglobal.org/health-impact-assessment", "https://www.isglobal.org/ehealth", "https://www.isglobal.org/biomedical-data-science", "https://www.isglobal.org/exposome-hub", "https://www.isglobal.org/implementation-science-hub", "https://www.isglobal.org/research-programmes", "#", "https://www.isglobal.org/maternal-child-reproductive", "https://www.isglobal.org/environment-and-health-over-the-lifecourse", "https://www.isglobal.org/malaria-and-neglected-parasitic-diseases", "https://www.isglobal.org/global-viral-and-bacterial-infections", "https://www.isglobal.org/climate-air-pollution-nature-and-urban-health", "https://www.isglobal.org/research/core-facilities", "https://www.isglobal.org/scientific-publications", "https://www.isglobal.org/innovation", "https://www.isglobal.org/coronavirus", "#", "https://www.isglobal.org/en/research-program/-/asset_publisher/l4JQXCybryTj/content/virus-emergentes", "https://www.isglobal.org/covid-19-novedades-cientificas", "https://www.isglobal.org/covid-19-estrategia-de-respuesta", "https://www.isglobal.org/preguntas-frecuentes-vacuna", "https://www.isglobal.org/gcmsc", "https://www.isglobal.org/es/healthisglobal?p_p_id=customblogportlet_WAR_customblogportlet&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&p_p_col_id=column-1&p_p_col_pos=1&p_p_col_count=3&p_r_p_564233524_categoryId=7806975", "https://www.isglobal.org/initiatives", "#", "https://www.isglobal.org/chagas", "#", "https://www.isglobal.org/enfermedad-de-chagas", "https://www.isglobal.org/coalicion-chagas", "https://www.isglobal.org/malaria-elimination", "#", "https://www.isglobal.org/la-caixa-contra-la-malaria", "https://www.isglobal.org/urban-planning", "#", "https://www.isglobal.org/ciudadesquequeremos", "https://www.isglobal.org/antimicrobial-resistance", "#", "https://www.isglobal.org/informe-la-batalla-contra-las-resistencias", "https://www.isglobal.org/maternal-child-and-reproductive-health", "#", "https://www.isglobal.org/epidemia-desigualdad", "https://www.isglobal.org/policy-and-development", "#", "https://www.isglobal.org/policy-and-development/what-we-do", "https://www.isglobal.org/ourteam-thinktank", "https://www.isglobal.org/lines-of-action", "https://www.isglobal.org/scientific-culture-unit", "https://www.isglobal.org/publications-thinktank", "https://www.isglobal.org/education", "#", "https://www.isglobal.org/presentacion", "#", "https://www.isglobal.org/equipo-formacion", "https://www.isglobal.org/training-programmes", "https://www.isglobal.org/capacity-strengthening", "https://www.isglobal.org/faculty", "https://www.isglobal.org/alumni", "https://www.isglobal.org/estudiar-en-barcelona", "https://www.isglobal.org/news-events", "#", "https://www.isglobal.org/news", "https://www.isglobal.org/events", "https://www.isglobal.org/press", "https://www.isglobal.org/healthisglobal", "https://www.isglobal.org/newsletter", "https://www.isglobal.org/archivo-multimedia", "https://www.isglobal.org/heat-index-calculator", "#", "/job-opportunities", "/press", "/find-us", "/es/covid19/haz-un-donativo", "/es/newsletter-form", "/es/newsletter-form", "https://www.isglobal.org/research", "https://www.isglobal.org/research-programmes", "/news?categoryIds=17612", "https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study", "https://twitter.com/share?url=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study&text=Estudio%20inmunol%C3%B3gico%20de%20la%20vacuna%20RTS%2CS", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study&title=Estudio%20inmunol%C3%B3gico%20de%20la%20vacuna%20RTS%2CS&summary=&source=ISGlobal", "mailto:?subject=Estudio%20inmunol%C3%B3gico%20de%20la%20vacuna%20RTS%2CS&body=", "http://www.sysmalvac.eu/", "/projects?categoryIds=5597611%2C59545", "https://www.isglobal.org/-/malaria-eradication-scientific-alliance-mesa-", "https://www.isglobal.org/-/nuevas-herramientas-para-el-diagnostico-y-la-evaluacion-del-paciente-con-enfermedad-de-chagas-nhepacha", "https://www.isglobal.org/-/euroleishnet", "https://www.isglobal.org/-/grepimer", "https://www.isglobal.org/-/teseo", "https://www.isglobal.org/-/bohemia", "https://www.isglobal.org/-/asintmal", "https://www.isglobal.org/-/genmoz", "https://www.isglobal.org/-/adam", "https://www.isglobal.org/-/multiply", "https://www.isglobal.org/-/enhanced-equitable-covid19-testing-treatment-bolivia-paraguay", "https://www.isglobal.org/-/science4pandemics", "https://www.isglobal.org/-/hiddenvivax", "https://www.isglobal.org/-/subclinical-infections-in-children-and-long-term-health-effects", "https://www.isglobal.org/-/impacto-de-las-coinfecciones-en-el-balance-de-respuestas-de-anticuerpos-y-linfocitos-t-helper-a-antigenos-diana-de-inmunidad-natural-y-vacunal-frente-", "https://www.isglobal.org/-/herramienta-innovadora-de-deteccion-de-enfermedades-y-vacunacion-a-poblacion-inmigrante-en-riesgo-en-espana", "https://www.isglobal.org/-/mena-migrant-health", "https://www.isglobal.org/-/sexmal", "https://www.isglobal.org/-/g_sensmalaria", "https://www.isglobal.org/-/epigen-building-scalable-pathogen-genomic-epidemiology-in-ethiopia", "https://www.isglobal.org/-/objetivo-salud-03-vacuna-contra-la-malaria-un-avance-historico", "https://www.isglobal.org/-/who-recommends-the-first-malaria-vaccine-for-children-at-risk", "https://www.isglobal.org/-/who-recommends-the-first-malaria-vaccine-for-children-at-risk", "https://www.isglobal.org/-/who-recommends-the-first-malaria-vaccine-for-children-at-risk", "https://www.isglobal.org/-/la-vacuna-rts-s-podria-favorecer-la-adquisicion-de-inmunidad-natural-contra-el-parasito-de-la-malaria", "https://www.isglobal.org/-/la-vacuna-rts-s-podria-favorecer-la-adquisicion-de-inmunidad-natural-contra-el-parasito-de-la-malaria", "https://www.isglobal.org/-/la-vacuna-rts-s-podria-favorecer-la-adquisicion-de-inmunidad-natural-contra-el-parasito-de-la-malaria", "https://www.isglobal.org/-/las-recomendaciones-de-la-oms-sobre-la-vacuna-rts-s-contra-la-malaria-un-logro-sin-precedentes", "https://www.isglobal.org/-/las-recomendaciones-de-la-oms-sobre-la-vacuna-rts-s-contra-la-malaria-un-logro-sin-precedentes", "https://www.isglobal.org/-/las-recomendaciones-de-la-oms-sobre-la-vacuna-rts-s-contra-la-malaria-un-logro-sin-precedentes", "https://www.isglobal.org/-/publicados-los-resultados-finales-de-la-vacuna-candidata-contra-la-malaria", "https://www.isglobal.org/-/publicados-los-resultados-finales-de-la-vacuna-candidata-contra-la-malaria", "https://www.isglobal.org/-/publicados-los-resultados-finales-de-la-vacuna-candidata-contra-la-malaria", "https://www.isglobal.org/-/carlota-dobano-ingresa-en-la-real-academia-de-farmacia-de-cataluna", "https://www.isglobal.org/-/carlota-dobano-ingresa-en-la-real-academia-de-farmacia-de-cataluna", "https://www.isglobal.org/-/carlota-dobano-ingresa-en-la-real-academia-de-farmacia-de-cataluna", "https://www.isglobal.org/-/nih-niaid-visits-cresib", "https://www.isglobal.org/-/nih-niaid-visits-cresib", "https://www.isglobal.org/-/nih-niaid-visits-cresib", "#", "#collapsePrivacyPolicy", "https://www.isglobal.org/research", "https://www.isglobal.org/research-programmes", "https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study", "https://twitter.com/share?url=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study&text=Pol%C3%ADtica%20de%20privacidad", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.isglobal.org%2F-%2Frts-s-vaccine-immunology-study&title=Pol%C3%ADtica%20de%20privacidad&summary=&source=ISGlobal", "mailto:?subject=Pol%C3%ADtica%20de%20privacidad&body=", "http://www.isglobal.org", "https://www.isglobal.org/es/politica-de-cookies", "mailto:lopd@isglobal.org", "https://www.aepd.es/", "mailto:lopd@isglobal.org", "#_cookies_WAR_cookiesportlet_cookiesTecnicas", "#_cookies_WAR_cookiesportlet_cookiesAnalisis", "#_cookies_WAR_cookiesportlet_cookiesThirdParty", "https://obrasociallacaixa.org/es/home", "http://www.hospitalclinic.org/", "http://www.parcdesalutmar.cat/es_index.html", "http://www.ub.edu/web/ub/es/", "http://www.upf.edu/es/", "http://www.gencat.cat/index_cas.htm", "http://www.lamoncloa.gob.es/", "http://www.bcn.cat/es/", "/", "https://www.isglobal.org/about-us", "https://www.isglobal.org/research", "https://www.isglobal.org/initiatives", "https://www.isglobal.org/policy-and-development", "https://www.isglobal.org/education", "https://www.isglobal.org/news-events", "/es/severo-ochoa", "https://cerca.cat/centres-cerca/", "https://www.isglobal.org/es/hrs4r", "http://www.facebook.com/isglobal", "http://twitter.com/ISGLOBALorg", "https://www.linkedin.com/company/1992859/", "https://www.instagram.com/isglobalorg/", "https://www.youtube.com/user/ISGLOBALorg", "/es/find-us", "/es/legal-warning", "/es/privacy-policy", "https://www.isglobal.org/es/politica-de-cookies"]}